Similar articles

• The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.

  Shand DG, Branch RA, Evans GH, Nies AS, Wilkinson GR. Shand DG, et al. Drug Metab Dispos. 1973 Sep-Oct;1(5):679-86. Drug Metab Dispos. 1973. PMID: 4149706 No abstract available.
• The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

  Evans GH, Nies AS, Shand DG. Evans GH, et al. J Pharmacol Exp Ther. 1973 Jul;186(1):114-22. J Pharmacol Exp Ther. 1973. PMID: 4198771 No abstract available.
• Propranolol disposition in chronic liver disease: a physiological approach.

  Branch RA, Shand DG. Branch RA, et al. Clin Pharmacokinet. 1976;1(4):264-79. doi: 10.2165/00003088-197601040-00002. Clin Pharmacokinet. 1976. PMID: 797499 Review.
• Effects of age and cigarette smoking on propranolol disposition.

  Vestal RE, Wood AJ, Branch RA, Shand DG, Wilkinson GR. Vestal RE, et al. Clin Pharmacol Ther. 1979 Jul;26(1):8-15. doi: 10.1002/cpt19792618. Clin Pharmacol Ther. 1979. PMID: 445965 No abstract available.
• Terminal half-lives of drugs studied in patients with hepatic diseases.

  Closson RG. Closson RG. Am J Hosp Pharm. 1977 May;34(5):520-4. Am J Hosp Pharm. 1977. PMID: 326043 Review.